PANMYCIN Drug Patent Profile
When do Panmycin patents expire, and when can generic versions of Panmycin launch?
Panmycin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in PANMYCIN is tetracycline hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Panmycin
A generic version of PANMYCIN was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PANMYCIN?
- What are the global sales for PANMYCIN?
- What is Average Wholesale Price for PANMYCIN?
Summary for PANMYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Patent Applications: | 6,867 |
| DailyMed Link: | PANMYCIN at DailyMed |
US Patents and Regulatory Information for PANMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | PANMYCIN | tetracycline hydrochloride | CAPSULE;ORAL | 060347-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | PANMYCIN | tetracycline hydrochloride | TABLET;ORAL | 061705-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmacia And Upjohn | PANMYCIN | tetracycline hydrochloride | TABLET;ORAL | 061705-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
